Thermo Fisher Scientific Inc.

Last price update: 23 Apr 24 23:00 GMT

Price:
$574.59
Open:
$567.51
Previous close:
$548.38
Day's range:
$560.17 - $576.69
Year's range:
$415.60 - $603.82
Net Income per Share:
15.46
Price-to-Earnings ratio:
37.17
52-week Price Range:
$570.63
Volume:
$2,543,396.00
Average volume:
$1,444,817.00

Company profile for Thermo Fisher Scientific Inc.

Thermo Fisher Scientific Inc. logo

Thermo Fisher Scientific Inc. is a leading provider of scientific instruments, reagents, and services to the global life science community. With products and services in the areas of analytical instruments, specialty diagnostics, laboratory products and services, and life sciences solutions, Thermo Fisher Scientific enables customers to make the world healthier, cleaner, and safer by providing leading-edge technologies and services to customers in academic and government research and clinical, pharmaceutical, biotechnology, and industrial markets.

The company is the world’s largest provider of analytical instruments, and provides customers with the largest portfolio of products and services in the world. It offers a comprehensive portfolio of products and services including gas chromatographs, mass spectrometers, PCR instrumentation, and cell analysis systems. It also offers reagents and consumables, specialty diagnostics and medical imaging equipment, laboratory products and services, and life sciences solutions.

Thermo Fisher Scientific has a strong presence in the life sciences market, including the biotechnology, pharmaceuticals, agricultural, and clinical markets. It has a wide range of products and services, including reagents, instruments, specialty diagnostics, and laboratory products and services. The company has also developed a strategic alliance with the University of California, San Francisco, to give customers access to the latest innovations and technologies.

Thermo Fisher Scientific has operations in more than 50 countries and employs over 75,000 people worldwide. It is headquartered in Waltham, Massachusetts, and is publicly traded on the New York Stock Exchange (NYSE: TMO). In 2020, the company generated annual revenues of $25 billion and had a market cap of over $100 billion. It has acquired over 50 companies since its founding in 1956 and has been listed as one of the Fortune 500 companies since 2003.

Stock exchanges:
NYSE
Sector:
Healthcare
Industries:
Diagnostics & Research
Ticker:
TMO
CIK:
97745
ISIN:
US8835561023
Website:
https://www.thermofisher.com
Phone:
781 622 1000
Origin:
United States
Employees:
130,000